Stock BIOPHARMX CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders BioPharmX Corp OTC Bulletin Board

Equities

US09072X1019

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for BioPharmX Corp
06/05 Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc. CI
04/04 First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc. CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Timber Pharmaceuticals, Inc. Announces Resignation of Zachary Rome, Effective March 4, 2022
CI
Insider Trends: Insider Prolongs 90-Day Selling Trend at Timber Pharmaceuticals
MT
Insider Trends: Insider Prolongs Selling Trend at Timber Pharmaceuticals
MT
Timber Pharmaceuticals : Names CEO John Koconis Chairman of the Board
MT
Timber Pharmaceuticals, Inc. Announces Board and Committee Changes
CI
Timber Pharmaceuticals, Inc Announces Resignation of Michael Derby as Executive Chairman
CI
Timber Pharmaceuticals, Inc. Announces Management Changes
CI
Timber Pharmaceuticals, Inc. Announces Board Changes
CI
Timber Pharmaceuticals, Inc. Announces Board Appointments
CI
Timber Pharmaceuticals, Inc. Appoints John Koconis as Chief Executive Officer in Place of Steven M. Bosacki
CI
Timber Pharmaceuticals, Inc. Appoints Joseph Lucchese as Chief Financial Officer
CI
Timber Pharmaceuticals, Inc. Announces Management Changes
CI
BioPharmX Corporation has Changed its Name to Timber Pharmaceuticals, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMBR Stock
  4. Stock
  5. News BioPharmX Corp
  6. Insiders